Best of 2020

Best of 2020

ReachMD Healthcare Image
RestartResume

A review and discussion of the key takeaways from three of the best articles in 2020 in the IBD Journal and Crohn’s & Colitis 360.

  • Overview

    Overview of main takeaways/clinical or research on three articles:

    • Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
    • The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    • Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences and Current Use in Australian Patients

Facebook Comments

Register

We’re glad to see you’re enjoying Crohn's Colitis Professional…
but how about a more personalized experience?

Register for free